Jazz Pharmaceuticals (JAZZ) PT Raised to $188 at Jefferies After Adding Xywav IH Indication to Model
Tweet Send to a Friend
Jefferies analyst David Steinberg raised the price target on Jazz Pharmaceuticals (NASDAQ: JAZZ) to $188.00 (from $151.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
